279 results
8-K
EX-99.1
AORT
Artivion Inc
30 Apr 13
CryoLife 2013 First Quarter Revenues Grew 10 Percent to a Record $35.5 Million
12:00am
the recognition of the 2012 research and development tax credits during the quarter.
Product revenues were $19.8 million for the first quarter … in the first quarter of 2013, compared to $1.7 million in the first quarter of 2012.
Research and development expenses were $2.0 million and $1.7 million
8-K
EX-99.1
AORT
Artivion Inc
1 Nov 07
CryoLife Reports Third Consecutive Profitable Quarter
12:00am
in the first nine months of 2006 were $30.8 million.
Research and development expenses were $1.1 million and $826,000 in the third quarters of 2007 and 2006 … , respectively. Research and development expenses were $3.1 million and $2.6 million in the first nine months of 2007 and 2006, respectively
8-K
EX-99.1
AORT
Artivion Inc
4 Nov 10
Results of Operations and Financial Condition
12:00am
pretax charges in the third quarter of 2010 of $3.7 million for acquired in-process research and development related to the Starch Medical … months of 2010 of $3.7 million for acquired in-process research and development related to the Starch Medical transaction, $3.6 million related
8-K
EX-99.1
AORT
Artivion Inc
16 Feb 12
Results of Operations and Financial Condition
12:00am
development activities and $2.3 million related to ongoing litigation.
Research and development expenses were $1.8 million and $2.0 million for the fourth … quarters of 2011 and 2010, respectively. Research and development expenses were $6.9 million and $5.9 million for the full year of 2011 and 2010
8-K
EX-99.1
AORT
Artivion Inc
19 Feb 09
CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
12:00am
increases in stock compensation expense over the same periods in the prior year.
Research and development expenses were $1.4 million for the fourth … quarter of 2008 compared to $1.3 million for the fourth quarter of 2007. Research and development expenses were $5.3 million and $4.5 million
8-K
EX-99.1
gfvi tv29k
17 Feb 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
kl9wkq2 vtpt
27 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
m8hwj8w1
26 Apr 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
91zyzm9y
30 Apr 08
CryoLife’s Earnings Per Share Increases 150 Percent to $0.10 in First Quarter of
12:00am
8-K
EX-99.1
97vffcjhtmp5hf
30 Oct 08
CryoLife’s Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
12:00am
8-K
EX-99.1
t7s5z4l guq4p2r
31 Jul 08
CryoLife’s Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
12:00am
8-K
EX-99.1
vic6fwelcp3 0g0n0ebw
28 Oct 14
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
51zle7harpthp6p1w
12 Jan 05
Termination of a Material Definitive Agreement
12:00am
8-K
EX-99.1
7l9hz
30 Jul 09
CryoLife Reports Record Quarterly Revenues of $28.2 Million
12:00am
8-K
EX-99.1
9sootfrees28egt602
14 Feb 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
9ypw1xi3 zlzsx2ce
29 Oct 09
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
dvd843tpniqofynkbav
30 Apr 09
Results of Operations and Financial Condition
12:00am
8-K
yz9 s4e96o
1 Nov 10
Departure of Directors or Certain Officers
12:00am